166 related articles for article (PubMed ID: 23034083)
21. Impact of HIV-1 Subtype on the Time to CD4+ T-Cell Recovery in Combination Antiretroviral Therapy (cART)-Experienced Patients.
Chow WZ; Lim SH; Ong LY; Yong YK; Takebe Y; Kamarulzaman A; Tee KK
PLoS One; 2015; 10(9):e0137281. PubMed ID: 26335136
[TBL] [Abstract][Full Text] [Related]
22. Immunological and virological responses to cART in HIV/HBV co-infected patients from a multicenter cohort.
Wang H; Li Y; Zhang C; Han Y; Zhang X; Zhu T; Li T
AIDS; 2012 Sep; 26(14):1755-63. PubMed ID: 22614885
[TBL] [Abstract][Full Text] [Related]
23. Does pregnancy affect the early response to cART?
Rachas A; Warszawski J; Le Chenadec J; Legeai C; Teglas JP; Goujard C; Rouzioux C; Mandelbrot L; Tubiana R; Meyer L
AIDS; 2013 Jan; 27(3):357-67. PubMed ID: 23079802
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment.
Murillo W; de Rivera IL; Parham L; Jovel E; Palou E; Karlsson AC; Albert J
HIV Med; 2010 Feb; 11(2):95-103. PubMed ID: 19686436
[TBL] [Abstract][Full Text] [Related]
25. Normalisation of CD4 counts in patients with HIV-1 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study.
Mocroft A; Phillips AN; Gatell J; Ledergerber B; Fisher M; Clumeck N; Losso M; Lazzarin A; Fatkenheuer G; Lundgren JD;
Lancet; 2007 Aug; 370(9585):407-13. PubMed ID: 17659333
[TBL] [Abstract][Full Text] [Related]
26. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
Panel de expertos de GESIDA y Plan Nacional sobre el Sida
Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
[TBL] [Abstract][Full Text] [Related]
27. Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort.
Rokx C; Fibriani A; van de Vijver DA; Verbon A; Schutten M; Gras L; Rijnders BJ;
Clin Infect Dis; 2015 Jan; 60(1):143-53. PubMed ID: 25273080
[TBL] [Abstract][Full Text] [Related]
28. CD4+ T cell count recovery in HIV type 1-infected patients is independent of class of antiretroviral therapy.
Khanna N; Opravil M; Furrer H; Cavassini M; Vernazza P; Bernasconi E; Weber R; Hirschel B; Battegay M; Kaufmann GR;
Clin Infect Dis; 2008 Oct; 47(8):1093-101. PubMed ID: 18783328
[TBL] [Abstract][Full Text] [Related]
29. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
30. The efficacy of combination antiretroviral therapy in HIV type 1-infected patients treated in Curaçao compared with Antillean, Surinam, and Dutch HIV type 1-infected patients treated in The Netherlands.
Hermanides HS; Gras L; Winkel CN; Gerstenbluth I; van Sighem A; de Wolf F; Duits AJ
AIDS Res Hum Retroviruses; 2011 Jun; 27(6):605-12. PubMed ID: 21155654
[TBL] [Abstract][Full Text] [Related]
31. Factors associated with virological response in HIV-infected patients failing antiretroviral therapy: a prospective cohort study.
Fournier S; Chaffaut C; Maillard A; Loze B; Lascoux C; Gérard L; Timsit J; David F; Bergmann JF; Oksenhendler E; Sereni D; Chevret S; Molina JM
HIV Med; 2005 Mar; 6(2):129-34. PubMed ID: 15807719
[TBL] [Abstract][Full Text] [Related]
32. Relationship between antiretrovirals used as part of a cART regimen and CD4 cell count increases in patients with suppressed viremia.
Mocroft A; Phillips AN; Ledergerber B; Katlama C; Chiesi A; Goebel FD; Knysz B; Antunes F; Reiss P; Lundgren JD
AIDS; 2006 May; 20(8):1141-50. PubMed ID: 16691065
[TBL] [Abstract][Full Text] [Related]
33. Changes in viral load in people with virological failure who remain on the same HAART regimen.
Cozzi-Lepri A; Phillips AN; Miller V; Katlama C; Ledergerber B; Vella S; Weber J; Bruun JN; Kirk O; Clotet B; Lundgrens JD
Antivir Ther; 2003 Apr; 8(2):127-36. PubMed ID: 12741625
[TBL] [Abstract][Full Text] [Related]
34. Effectiveness and pitfalls of initial highly active antiretroviral therapy in HIV-infected patients in routine clinical practice.
Moreno A; Perez-Elías MJ; Casado JL; Muñoz V; Antela A; Dronda F; Navas E; Fortún J; Quereda C; Moreno S
Antivir Ther; 2000 Dec; 5(4):243-8. PubMed ID: 11142618
[TBL] [Abstract][Full Text] [Related]
35. Impaired CD4 T-cell count response to combined antiretroviral therapy in antiretroviral-naive HIV-infected patients presenting with tuberculosis as AIDS-defining condition.
Cingolani A; Cozzi Lepri A; Castagna A; Goletti D; De Luca A; Scarpellini P; Fanti I; Antinori A; d'Arminio Monforte A; Girardi E
Clin Infect Dis; 2012 Mar; 54(6):853-61. PubMed ID: 22157323
[TBL] [Abstract][Full Text] [Related]
36. Considerable under-treatment of chronic HCV infection in HIV patients despite acceptable sustained virological response rates in a real-life setting.
Reiberger T; Obermeier M; Payer BA; Baumgarten A; Weitner L; Moll A; Christensen S; Köppe S; Kundi M; Rieger A; Peck-Radosavljevic M
Antivir Ther; 2011; 16(6):815-24. PubMed ID: 21900713
[TBL] [Abstract][Full Text] [Related]
37. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care.
Sobrino-Vegas P; Rodríguez-Urrego J; Berenguer J; Caro-Murillo AM; Blanco JR; Viciana P; Moreno S; Bernardino I; del Amo J;
Antivir Ther; 2012; 17(1):1-8. PubMed ID: 22267463
[TBL] [Abstract][Full Text] [Related]
38. Viro-immunological dynamics in HIV-1-infected subjects receiving once-a-week emtricitabine to delay treatment change after failure: a pilot randomised trial.
Soria A; Danise A; Galli L; Tiberi S; Seminari E; Cossarini F; Bigoloni A; Marcotullio S; Lazzarin A; Castagna A
J Clin Virol; 2010 Mar; 47(3):253-7. PubMed ID: 20056480
[TBL] [Abstract][Full Text] [Related]
39. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
40. Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients.
Rodes B; García F; Gutierrez C; Martinez-Picado J; Aguilera A; Saumoy M; Vallejo A; Domingo P; Dalmau D; Ribas MA; Blanco JL; Pedreira J; Perez-Elias MJ; Leal M; de Mendoza C; Soriano V;
J Med Virol; 2005 Sep; 77(1):23-8. PubMed ID: 16032728
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
